Marelius; Gulin Erdogan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Marelius; Gulin Erdogan.The latest application filed is for "compositions and methods of treating muscle atrophy and myotonic dystrophy".

Company Profile

7.8.15

Marelius; Gulin Erdogan - San Diego CA
Marelius; Gulin Erdogan - Boston MA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and methods of treating muscle dystrophy Grant 11,446,387 - Doppalapudi , et al. September 20, 2	2022-09-20
Modulators of cystic fibrosis transmembrane conductance regulator Grant 11,426,407 - Miller , et al. August 30, 2	2022-08-30
Compositions And Methods Of Treating Muscle Atrophy And Myotonic Dystrophy App 20220133900 - GEALL; Andrew John ; et al.	2022-05-05
Compositions And Methods Of Treating Muscle Atrophy And Myotonic Dystrophy App 20220096647 - GEALL; Andrew John ; et al.	2022-03-31
Compositions And Methods Of Treating Muscle Atrophy And Myotonic Dystrophy App 20220062434 - GEALL; Andrew John ; et al.	2022-03-03
Compositions and methods of treating muscle atrophy and myotonic dystrophy Grant 11,253,607 - Geall , et al. February 22, 2	2022-02-22
Compositions and methods of treating muscle atrophy and myotonic dystrophy Grant 11,246,941 - Geall , et al. February 15, 2	2022-02-15
Compositions And Methods Of Treating Muscle Atrophy And Myotonic Dystrophy App 20220040323 - GEALL; Andrew John ; et al.	2022-02-10
Compositions And Methods Of Treating Muscle Atrophy And Myotonic Dystrophy App 20220040322 - GEALL; Andrew John ; et al.	2022-02-10
Compositions And Methods Of Treating Muscle Atrophy And Myotonic Dystrophy App 20220008550 - GEALL; Andrew John ; et al.	2022-01-13
Compositions And Methods Of Treating Muscle Dystrophy App 20210299266 - DOPPALAPUDI; Venkata Ramana ; et al.	2021-09-30
Compositions And Methods Of Treating Muscle Atrophy And Myotonic Dystrophy App 20210187116 - GEALL; Andrew John ; et al.	2021-06-24
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20210052584 - Miller; Mark Thomas ; et al.	2021-02-25
Compositions and methods of treating muscle atrophy and myotonic dystrophy Grant 10,881,743 - Geall , et al. January 5, 2	2021-01-05
Compositions And Methods Of Treating Muscle Atrophy And Myotonic Dystrophy App 20200405877 - GEALL; Andrew John ; et al.	2020-12-31
Modulators of cystic fibrosis transmembrane conductance regulator Grant 10,758,534 - Miller , et al. Sep	2020-09-01
Compositions And Methods Of Treating Muscle Atrophy And Myotonic Dystrophy App 20190298847 - GEALL; Andrew John ; et al.	2019-10-03
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20190269683 - Miller; Mark Thomas ; et al.	2019-09-05
Modulators of cystic fibrosis transmembrane conductance regulator Grant 10,258,624 - Miller , et al.	2019-04-16
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20180185364 - Miller; Mark Thomas ; et al.	2018-07-05
Modulators of cystic fibrosis transmembrane conductance regulator Grant 9,782,408 - Miller , et al. October 10, 2	2017-10-10
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20170196862 - Miller; Mark Thomas ; et al.	2017-07-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.